Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Rhabdoid Tumor × Methotrexate × Clear all

Phase

Phase EARLY_PHASE1 2 Phase 3 2 Phase 2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 88 Leukemia 83 Lymphoma 70 Burkitt Lymphoma 45 Leukemia, Myeloid, Acute 42 Lymphoma, Non-Hodgkin 36 Myelodysplastic Syndromes 34 Lymphoma, Large B-Cell, Diffuse 33 Lymphoma, Mantle-Cell 31 Leukemia, Lymphocytic, Chronic, B-Cell 29 Lymphoma, Follicular 26 Leukemia, Myeloid, Accelerated Phase 24 Hodgkin Disease 24 Graft vs Host Disease 24 Congenital Abnormalities 22 Breast Neoplasms 22 Blast Crisis 22 Leukemia, Myeloid, Chronic-Phase 21 Lymphoma, B-Cell, Marginal Zone 20 Myeloproliferative Disorders 19 Multiple Myeloma 19 Lymphoma, Large-Cell, Immunoblastic 19 Leukemia, Myelomonocytic, Chronic 18 Recurrence 14 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 14 Dendritic Cell Sarcoma, Interdigitating 14 Primary Myelofibrosis 13 Neoplasms, Plasma Cell 13 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 13 Anemia, Refractory, with Excess of Blasts 13

Interventions

Magnetic Resonance Spectroscopy 7 X-Rays 6 Phantoms, Imaging 6 Specimen Handling 5 Nuclear Medicine Department, Hospital 5 Cyclophosphamide 4 Biopsy 4 palbociclib 3 Topotecan 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 olaparib 2 larotrectinib 2 ivosidenib 2 etoposide phosphate 2 erdafitinib 2 ensartinib 2 Vemurafenib 2 LY3023414 2 Etoposide 2 selinexor 1 cabozantinib 1 antineoplaston AS 2-1 1 antineoplaston A10 1 Vincristine 1 Temozolomide 1 Stem Cell Transplantation 1 Sirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02114229 2026-03-17

SJATRT

St. Jude Children's Research Hospital

Phase 2 Active not recruiting

Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡